Attached files

file filename
10-Q/A - 10-Q/A - BioRestorative Therapies, Inc.v232728_10qa.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R3.htm
EXCEL - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R11.htm
v2.3.0.11
Condensed Consolidated Balance Sheets (USD $)
Jun. 30, 2011
Dec. 31, 2010
Current Assets:    
Cash $ 7,185 $ 18,074
Prepaid expenses and other current assets 58,170  
Total Current Assets 65,355 18,074
Property and equipment, net 412,309 446,756
Intangible assets, net 3,492 3,676
Security deposit 4,415  
Total Assets 485,571 468,506
Current Liabilities:    
Accounts payable 308,479 160,187
Accrued expenses and other current liabilities 577,675 341,618
Notes payable, net of debt discount of $76,118 and $19,476 at June 30, 2011 and December 31, 2010, respectively 1,928,236 514,047
Total Current Liabilities 2,814,390 1,015,852
Notes payable - less current maturities 153,682 196,876
Total Liabilities 2,968,072 1,212,728
Commitments and contingencies    
Stockholders' Deficiency:    
Preferred stock, $0.01 par value; Authorized, 1,000,000 shares; none issued and outstanding at June 30, 2011 and December 31, 2010    
Common stock, $0.001 par value; Authorized, 800,000,000 shares at June 30, 2011 and December 31, 2010; Issued, 584,643,645 and 461,148,534 shares at June 30, 2011 and December 31, 2010, respectively; Outstanding, 556,712,611 and 433,217,500 shares at June 30, 2011 and December 31, 2010, respectively 584,644 461,149
Additional paid-in capital 2,733,353 2,270,219
Shares issuable   6,971
Deficit accumulated during development stage (5,768,498) (3,450,561)
Treasury stock, at cost, 27,931,034 shares at June 30, 2011 and December 31, 2010 (32,000) (32,000)
Total Stockholders' Deficiency (2,482,501) (744,222)
Total Liabilities and Stockholders' Deficiency $ 485,571 $ 468,506